AN OPEN LABEL PHASE I STUDY TO EVAL THE SAFETY AND TOLERABILITY OF A VACCINE (GI-6207) CONSISTING OF WHOLE, HEAT-KILLED RECOMBINANT SACCHAROMYCES CEREVISIAE (YEAST) GENETICALLY MODIFIED TO EXPRESS CEA PROTEIN IN ADULTS WITH METASTATIC CEA-EXPRESSING ...: